Search Results - "Donner, Markus G"

Refine Results
  1. 1

    Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate by Bode, Konrad A, Donner, Markus G, Leier, Inka, Keppler, Dietrich

    Published in Biochemical pharmacology (01-07-2002)
    “…Hyperbilirubinemia is a frequent side effect induced by long-term therapy with the antibiotic fusidate. The aim of this study was to elucidate the molecular…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS by Donner, Markus G, Warskulat, Ulrich, Saha, Nirmalendu, Häussinger, Dieter

    Published in Biological chemistry (01-03-2004)
    “…Lipopolysaccharide (LPS) induces hepatocellular down-regulation and endocytic retrieval of multidrug resistance protein 2 (Mrp2, Abcc2). Basolateral Mrp…”
    Get more information
    Journal Article
  6. 6

    Favourable Outcome in Two Pregnancies in a Patient with 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency by Santosa, David, Donner, Markus G., vom Dahl, Stephan, Fleisch, Markus, Hoehn, Thomas, Mayatepek, Ertan, Heldt, Katrin, Niehues, Tim, Häussinger, Dieter

    Published in JIMD Reports, Volume 37 (01-01-2017)
    “…In patients with 3-hydroxy-3-methylglutaryl(HMG)-CoA lyase deficiency (OMIM 246450), five pregnancies have been described worldwide, which were either…”
    Get full text
    Book Chapter Journal Article
  7. 7

    Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2 by Donner, Markus G, Schumacher, Stephanie, Warskulat, Ulrich, Heinemann, Jane, Häussinger, Dieter

    “…Inverse acinar regulation of Mrp2 and 3 represents an adaptive response to hepatocellular cholestatic injury. We studied whether obstructive cholestasis (bile…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia by Richter, Werner O., Donner, Markus G., Höfling, Berthold, Schwandt, Peter

    Published in Metabolism, clinical and experimental (01-07-1998)
    “…Low-density lipoprotein (LDL) apheresis is a potent treatment for patients with coronary heart disease and severe hereditary forms of LDL hypercholesterolemia…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile by Donner, Markus G., Klein, Gernot K., Mathes, Peter B., Schwandt, Peter, Richter, Werner O.

    Published in Metabolism, clinical and experimental (01-03-1998)
    “…Mild hyperhomocysteinemia has been associated with an increased risk to develop premature coronary heart disease. Recently, the homocysteine concentration has…”
    Get full text
    Journal Article
  15. 15

    Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis by Donner, Markus G., Parhofer, Klaus G., Richter, Werner O., Schwandt, Peter

    Published in Metabolism, clinical and experimental (01-07-1999)
    “…Oxidation of low-density lipoprotein (LDL) plays a major role in the development of atherosclerosis. Hypercholesterolemia has been associated with enhanced in…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Short- and long-term effects on serum lipoproteins by three different techniques of apheresis by Richter, W O, Donner, M G, Schwandt, P

    Published in Artificial organs (01-04-1996)
    “…Low-density lipoprotein (LDL) apheresis is applied in patients with coronary heart disease because of severe inherited forms of hypercholesterolemia, for which…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Three Low Density Lipoprotein Apheresis Techniques in Treatment of Patients with Familial Hypercholesterolemia: A Long-Term Evaluation by Richter, Werner O., Donner, Markus G., Schwandt, Peter

    Published in Therapeutic apheresis (01-08-1999)
    “…Low density lipoprotein (LDL) apheresis is a treatment option for patients with severe hypercholesterolemia not adequately responding to drug treatment who…”
    Get full text
    Journal Article